Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 12, 2008, Pages 1726-1728

  Pudil, Radek ^a   Pařízek, Petr ^a   Tichý, Miloš ^a,b   Haman, Luděk ^a,b   Horáková, Lucie ^a   Ulrychová, Martina ^a   Vojáček, Jan ^a   Palička, Vladimír ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Biochip microarray system; Cardiac troponin I; Creatine kinase isoenzyme MB (CK MB); Glycogen phosphorylase isoenzyme BB; Heart type fatty acid binding protein; Myocardial injury; Radiofrequency catheter ablation

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; GLYCOGEN PHOSPHORYLASE; TROPONIN I;

ADULT; ARTICLE; BIOCHIP; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART MUSCLE INJURY; HUMAN; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REENTRY TACHYCARDIA;

ADULT; BIOLOGICAL MARKERS; CATHETER ABLATION; FEMALE; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 57449093578     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.341     Document Type: Article

References (15)

1. Morady F. Radiofrequency ablation as treatment for cardiac arrhythmia. N Engl J Med 1999;340:534-44.
2. Haines DE, Whayne JG, Walker J, Nath S, Bruns D. The effect of radiofrequency catheter ablation on myocardial creatine kinase activity. J Cardiovasc Electrophysiol 1995;6:79-88.
3. Dolci A, Pantegini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 2006;369:179-87.
4. Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J 2004;25:1187-96.
5. Colli A, Josa M, Pomar JL, Mestres CA, Gherli T. Heart fatty acid binding protein in the diagnosis of myocardial infarction: where do we stand today? Cardiology 2007;108:4-10.
6. Peetz D, Post F, Schnitzel H. Glycogen phosphorylase BB in acute coronary syndromes. Clin Chem Lab Med 2005;43:1351-8.
7. Kay GN, Epstein AE, Dailey SM, Plumb VJ. Role of radiofrequency catheter ablation in management of supraventricular arrhythmias: experience in 76 consecutive patients. J Cardiovasc Electrophysiol 1993;4:371-89.
8. Manolis AS, Vassilikos V, Maounis T, Melita-Manolis H, Psarros L, Haliasos A, et al. Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: procedural correlates. J Am Coll Cardiol 1999;34:1099-105.
9. Emkanjoo Z, Mottayden M, Givtaj N, Alasti M, Arya A, Haghjoo M, et al. Evaluation of post-radiofrequency myocardial injury by measuring cardiac troponin I levels. Int J Cardiol 2007;117:173-7.
10. Brown CS, Bertolet BD. Cardiac troponin: see ya later, CK! Chest 1997;111:2-4.
11. Apple F, Wu A, Mair J, Ravkilde J, Panteghini M, Tate J, et al. Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndromes. Clin Chem 2005;51:810-24.
12. Koichi S, Yoshihiko S, Teruo T. Heart-type fatty acid-binding protein is an integrated cardio-renal marker in patients with chronic heart failure. J Card Failure 2006;12:S178.
13. Bednarek J, Tomala I, Majewsky J, Szcepovski J, Lelakowski J. Biochemical markers of myocardial damage after radiofrequency ablation. Kardiol Pol 2004;60:335-41.
14. Hirose H, Kato K, Suzuki O, Yoshida T, Oguri M, Yajima K, et al. Diagnostic accuracy of cardiac markers for myocardial damage after radiofrequency catheter ablation. J Interv Card Electrophysiol 2006;16:169-74.
15. Ozdemir M, Durakoglugil E, Gulbahar O, Turkoglu S, Sancak B, Paşaoǧlu H, et al. Heart fatty acid binding protein and myoglobin after reperfusion of acute myocardial infarction. Acta Cardiol 2007;62:473-8.